Follow The Filings

TEVA position history

The shares of Teva Pharmaceutical Industries (TEVA) that SOUND SHORE MANAGEMENT INC reported in each quarter’s 13F.

Equity, SPONSORED ADS

Shares held by quarter

New Add Reduce Exit

  1. 2023 Q3: 7,920,712 shares, $81M, 3.1% of portfolio, New
  2. 2023 Q4: 8,919,234 shares, $93M, 3.2% of portfolio, Add +12.6%
  3. 2024 Q1: 7,494,690 shares, $106M, 3.3% of portfolio, Reduce −16.0%
  4. 2024 Q2: 6,761,446 shares, $110M, 3.7% of portfolio, Reduce −9.8%
  5. 2024 Q3: 5,976,844 shares, $108M, 3.5% of portfolio, Reduce −11.6%
  6. 2024 Q4: 4,772,712 shares, $105M, 3.5% of portfolio, Reduce −20.1%
  7. 2025 Q1: 5,452,089 shares, $84M, 2.9% of portfolio, Add +14.2%
  8. 2025 Q2: 5,846,512 shares, $98M, 3.3% of portfolio, Add +7.2%
  9. 2025 Q3: 5,647,449 shares, $114M, 3.8% of portfolio, Reduce −3.4%
  10. 2025 Q4: 4,309,906 shares, $135M, 4.3% of portfolio, Reduce −23.7%
  11. 2026 Q1: 3,885,683 shares, $117M, 3.9% of portfolio, Reduce −9.8%
  12. 2026 Q2: 3,804,497 shares, $129M, 4.0% of portfolio, Reduce −2.1%
  13. 2026 Q3: not held, Exit
Holdings date Value % of holdings Shares Filing date All 13F holders